
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Osteosarcoma laboratory findings
Introduction
Overview
Overview
Laboratory tests for osteosarcoma include complete blood count (CBC), serum alkaline phosphatase and lactate dehydrogenase.
Laboratory Tests
Laboratory Tests
Laboratory tests for osteosarcoma include the following:[1][2][3][4][5]
- Complete blood count (CBC), including differential
- Platelet count
- Liver function tests:
- Electrolyte levels – Sodium, potassium, chloride, bicarbonate, calcium, magnesium, phosphorus
- Renal function tests – Blood urea nitrogen(BUN), creatinine
- Urinalysis
- Blood chemistry studies include:
References
References
- ↑ Kim HJ, Chalmers PN, Morris CD (February 2010). “Pediatric osteogenic sarcoma”. Curr. Opin. Pediatr. 22 (1): 61–6. doi:10.1097/MOP.0b013e328334581f. PMID 19915470.
- ↑ Moore DD, Luu HH (2014). “Osteosarcoma”. Cancer Treat. Res. 162: 65–92. doi:10.1007/978-3-319-07323-1_4. PMID 25070231.
- ↑ Ilaslan H, Schils J, Nageotte W, Lietman SA, Sundaram M (March 2010). “Clinical presentation and imaging of bone and soft-tissue sarcomas”. Cleve Clin J Med. 77 Suppl 1: S2–7. doi:10.3949/ccjm.77.s1.01. PMID 20179183.
- ↑ Wu PK, Chen WM, Lee OK, Chen CF, Huang CK, Chen TH (November 2010). “The prognosis for patients with osteosarcoma who have received prior manipulative therapy”. J Bone Joint Surg Br. 92 (11): 1580–5. doi:10.1302/0301-620X.92B11.24706. PMID 21037356.
- ↑ Obiedat H, Alrabadi N, Sultan E, Al Shatti M, Zihlif M (July 2018). “The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients”. BMC Med. Genet. 19 (1): 112. doi:10.1186/s12881-018-0627-4. PMC 6035436. PMID 29980176.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammadmain Rezazadehsaatlou[2].
